The enhanced clinical efficacy by treated years and the sustained efficacy after treatment of sublingual immunotherapy for Japanese cedar pollinosis

Japanese Journal of Allergology

Volumn 59, Issue 11, 2010, Pages 1552-1561

  Yuta, Atsushi ^a   Ogihara, Hitomi ^a   Miyamoto, Yukiko ^a   Takeuchi, Kazuhiko ^a   Okubo, Kimihiro ^b  

^a MIE UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Japanese cedar; Pollinosis; Sublingual immunotherapy

Indexed keywords

ARTICLE; CLINICAL ARTICLE; HUMAN; IMMUNOTHERAPY; JAPANESE CEDAR; NOSE CONGESTION; POLLEN ALLERGY; RHINORRHEA; SNEEZING;

ADMINISTRATION, SUBLINGUAL; ADULT; ALLERGENS; CRYPTOMERIA; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, SEASONAL; TIME FACTORS;

EID: 78650849941     PISSN: 00214884     EISSN: 13477935     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Prog Med 2008; 28: 2001-12.
2. Mebio 2010; 27: 42-9.
3. Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-75.
4. Bousquet J, Lockey RF, Mailing HJ. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53 (suppl): 1-42. (Pubitemid 28346358)
5. Okubo K, Gotoh M, Fujieda S, Okano M, Yoshida H, Morikawa H, et al. A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis. Allergol Int 2008; 57: 265-75.
6. Passalacqua G, Guerra L, Compalati E, Fumagalli F, Cirillo A, Canonica GW. New insights in sublingual immunotherapy. Curr Allergy Asthma Rep 2006; 6: 407-12.
7. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008; 86: 101-2.